Lalezari says that overall, the anti-virals will fail to be the game changer, and soon there will be "more oxygen in the room" (horrible pun!) for leronlimab as a treatment, because once you have the virus, it does it's "job" quickly by attacking the lungs, and it is leronlimab that is going to be the treatment of choice.